Ondine Biomedical (LON:OBI) Trading Up 3.4% – What’s Next?

Ondine Biomedical Inc. (LON:OBI)’s stock price was up 3.4% during trading on Thursday . The company traded as high as C$15.50 and last traded at C$15.00. Approximately 381,523 shares traded hands during mid-day trading, a decline of 12% from the average daily volume of 435,847 shares. The stock had previously closed at C$14.50.

Ondine Biomedical Stock Performance

The business’s 50-day moving average price is C$11.67 and its 200-day moving average price is C$10.60. The company has a debt-to-equity ratio of 76.45, a quick ratio of 8.26 and a current ratio of 0.97. The stock has a market cap of C$7.97 billion, a P/E ratio of -2.19 and a beta of 0.27.

Ondine Biomedical Company Profile

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target.

Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.